RLMD

Relmada Therapeutics Inc

Jun 04 • 11:39AM ET

6.39

+0.06 0.87 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: AXSM KYMR RYTM INCY NUVL BMRN NBIX VKTX KRYS MDGL

| Held by: VTI VXF PSIL ITOT ONEQ PRFZ AVSC AVUS IBRN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.11	Insider Own	12.21%	Shs Outstand	104.89M	Perf Week	-11.93%
Market Cap	669.73M	Forward P/E	-	EPS next Y	-0.96	Insider Trans	0.31%	Shs Float	92.08M	Perf Month	-13.13%
Enterprise Value	435.77M	PEG	-	EPS next Q	-0.19	Inst Own	71.10%	Short Float	5.96%	Perf Quarter	44.13%
Income	-58.88M	P/S	-	EPS this Y	44.83%	Inst Trans	40.91%	Short Ratio	2.92	Perf Half Y	58.04%
Sales	0.00M	P/B	3.06	EPS next Y	-19.75%	ROA	-44.77%	Short Interest	5.49M	Perf YTD	32.19%
Book/sh	2.09	P/C	2.86	EPS next 5Y	12.24%	ROE	-48.83%	52W High	8.00 -20.19%	Perf Year	765.29%
Cash/sh	2.23	P/FCF	-	EPS past 3/5Y	35.03% 17.54%	ROIC	-26.92%	52W Low	0.52 1127.88%	Perf 3Y	125.62%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.99% 6.45%	Perf 5Y	-78.81%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	55.59%	Oper. Margin	-	ATR (14)	0.41	Perf 10Y	-42.16%
Dividend Ex-Date	-	Quick Ratio	18.26	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	38.47	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	18.26	EPS Q/Q	61.90%	SMA20	-9.46%	Beta	0.42	Target Price	12.80
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-10.15%	Rel Volume	0.33	Prev Close	6.33
Employees	17	LT Debt/Eq	0.00	Earnings	May 12 AMC	SMA200	47.49%	Avg Volume	1.88M	Price	6.39
IPO	Jun 20, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.84% -	Trades		Volume	227,202	Change	0.87%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)